Previous Pause Next
Home >> News Center >>
Effects of Iodine Supplements on Maternal Thyroid Function Studied PDF Print E-mail
User Rating :  / 0
Monday, 08 March 2010 02:24
Iodine is an essential element for synthesising thyroid hormones. A team of researchers from the Childhood and Environment Project (INMA) has studied the consequences of pregnant women consuming it in their diet and in supplements. The results suggest the need to evaluate their iodine nutritional status before systematically recommending taking it during pregnancy.

"Good iodine nutritional status at the start of and during pregnancy is essential for maintaining proper thyroid function in the mother and encouraging healthy brain development in the foetus and psycho-motor development in the child," says Marisa Rebagliato, lead author of the study and a researcher at the INMA Project, a research network of Spanish groups studying the effects of environmental contaminants during pregnancy and the start of life.

"When women begin pregnancy with sufficient levels of iodine through having previously taken iodine in their diet and iodised salt, the iodine reserves in their thyroid glands are sufficient to ensure proper synthesis of thyroid hormones, and pharmacological supplements are not recommended," says the scientist.

The research, published recently in the journal Epidemiology, evaluated the consumption of iodine in foodstuffs, iodised salt and vitamin supplements, as well as ioduria (iodine content in urine) of 1,844 pregnant women in the Spanish provinces of Guipúzcoa, Valencia, and the city of Sabadell, between 2004 and 2008. The objective was to study the relationship between their iodine nutritional status and thyroid function during the first half of pregnancy.

Contrary to what the authors had expected, pregnant women who consumed 200 μg or more in iodine supplements each day "were at greater risk of having high levels of thyroid stimulating hormones (TSH), indicators of possible thyroid dysfunction."

Out of all the pregnant women, 44% ate iodised salt and 49% took multivitamins containing iodine or specific iodine supplements containing at least 100 μg of iodine. The overall results show that the 'median ioduria, an indicator used to assess iodine nutritional status, was 137 μg/litre, and was within the correct limits for the population at large, although "slightly" below the levels recommended by the World Health Organisation (WHO) for pregnancy (150-249μg/l).

Various studies on the general population have shown a link between high iodine consumption and hypothyroidism. "However, data for pregnant woman are scarce and inconclusive. There is consensus, though, that the risks stemming from iodine deficiency, for the health of both mother and child, are greater than those from risks due to excessive iodine consumption," points out the researcher.

The team stresses a basic message. "Epidemiological monitoring of nutritional iodine status should be carried out on this population before making any automatic recommendations about taking iodine supplements during pregnancy. And above all, people should be encouraged to take iodised salt to ensure they have sufficient iodine levels long before pregnancy."

Adapted from materials provided by FECYT - Spanish Foundation for Science and Technology, via EurekAlert!, a service of AAAS.

Journal Reference:

1.Rebagliato M., Murcia M., Espada M., Álvarez-Pedrerol M., Bolúmar F., Vioque J., Basterrechea M., Blarduni E., Ramón R., Guxens M., Foradada C. M., Ballester F., Ibarluzea J., y Sunyer J. Iodine Intake and Maternal Thyroid Function During Pregnancy :. Epidemiology, 2010; 21 (1): 62 DOI: 10.1097/EDE.0b013e3181c1592b

Abstract

Background: An adequate iodine intake during pregnancy is essential for the synthesis of maternal thyroid hormones and normal brain development in the fetus. Scant evidence is available on the effects and safety of iodine supplementation during pregnancy in areas with adequate or mildly deficient iodine intake. We examined the association of maternal iodine intake and supplementation with thyroid function before 24 weeks of gestation in population-based samples from 3 different areas in Spain.

Methods: A cross-sectional study of 1844 pregnant women (gestational age range 8–23 weeks) was carried out in 3 areas in Spain (Guipúzcoa, Sabadell, Valencia), during the period 2004–2008. We measured levels of free thyroxine and thyroid-stimulating hormone (TSH) in serum, iodine in a spot urine sample, and questionnaire estimates of iodine intake from diet, iodized salt and supplements. Adjusted associations were assessed by multiple linear regression and logistic regression analyses.

Results: There was an increased risk of TSH above 3 μU/mL in women who consumed 200 μg or more of iodine supplements daily compared with those who consumed less than 100 μg/day (adjusted odds ratio = 2.5 [95% confidence interval = 1.2 to 5.4]). We observed no association between urinary iodine and TSH levels. Pregnant women from the area with the highest median urinary iodine (168 μg/L) and highest supplement coverage (93%) showed the lowest values of serum free thyroxine. (geometric mean = 10.09 pmol/L [9.98 to 10.19]).

Conclusions: Iodine supplement intake in the first half of pregnancy may lead to maternal thyroid dysfunction in iodine-sufficient or mildly iodine-deficient populations.

 
FairExcellent 

Add comment  |   Add to my library  |  Forward this article

login to leave comment

Collaboration, Projects, & Consortia

TGen, Karmanos Lead $6M Melanoma Project

Sanford-Burnham Medical Research Institute and Pfizer Collaborate to Speed Drug Discovery

e2v aerospace and defense and Maxim Announce an Agreement to Extend the Product Life of Maxim Ceramic ICs

Syntaxin and Ipsen Ally to Develop Botulinum Toxin Therapeutics

BioAmber and LANXESS Partner for Renewable, Phthalate-free Plasticizers

Corgenix Partners with AXA Diagnostics on SkyLAB 752™ Automated Testing Platform

GeoVax and Vivalis Sign Deal for the Biomanufacture of MVA HIV Vaccine in EB66 Cells

EMD Serono and Fast Forward Commit $3 Million for Multiple Sclerosis

VisionGate Begins Collaborations to Evaluate 3-D Cell Analysis Test for Lung Cancer Screening

VaxyGen Manufacturing Services LLC Announces Exclusive License and Collaborative Agreement with Georgia State University Research Foundation to Commercialize Novel Biological Process Development Patent, Expertise & Know-How

>> More in: Collaboration, Projects and Consortia

Featured Experts

Featured Laboratories

Grant & Funding Opportunities

NHGRI Unveils New-Look Genome Sequencing Program; Plans $416M in Funding

NYU to Study Genetics of Obesity-Related Cancers

Researchers Get NHGRI Funding to Study Effects of Alzheimer's Risk Testing

Venture Firms Pump $18M into Fledgling Arteaus Therapeutics

Servier and miRagen Sign $352M Deal for Cardiovascular miRNA Therapeutics

Tetraphase Awarded Initial $6M by NIAID to Develop Antibiotic Against Biothreats

Dermira Announces a $42m Series A Financing to Fund Therapeutic Advances in Dermatology

Salk Institute for Biological Studies to Accelerate Brain Research With $4.5 Million National Institutes of Health (NIH) Grant

Arsanis Wins €1.2M for Research on Antibody Against Hospital-Acquired Infections

SAMHSA Awards Approximately $1.3 Million To Help Communities Offer Expanded HIV Testing, Counseling And Referral For Care

>> More in: Grant & Funding Opportunities

Hot Papers

New fluorescent dyes highlight neuronal activity

Study reveals enzyme function, could help find muscular dystrophy therapies

Breakthrough in Treatment to Prevent Blindness

Vision Scientists Demonstrate Innovative Learning Method

Scripps research scientists develop brand new class of small molecules through innovative chemistry

Scripps research team achieves critical step to opening elusive class of compounds to drug discovery

Nobel Laureate Bruce Beutler on molecular sensors as a trigger for autoimmune disease

Talk to the Virtual Hands: Body Language of Both Speaker and Listener Affects Success in Virtual Reality Communication Game

Sniffing out the Brain's Predictive Power: Human Brain 'Smells' What It Expects Rather Than What It Sniffs

Children Find Human-Made Objects More Likely to Be Owned Than Natural Objects

>> More in: Top 5 papers (Hot Papers)

Appointments

Sanofi (France) Taps David Meeker as New CEO of Genzyme Corporation

Drug Information Association Appoints Kaushik Desai as DIA India Director

Sentrx Announces Resignation of Charles T. Saldarini As CEO

EKR Therapeutics Announces Senior Management Change

Amgen Appoints Robert A. Bradway to the Company's Board of Directors

Anavex Life Sciences Corp. Appoints Dr. George Tidmarsh as Executive Director

Isis Biopolymer Appoints New President and CEO

RedHill Biopharma Appoints Key Opinion Leader Professor David Y. Graham from Baylor College of Medicine, Houston, Texas, as Lead Investigator for the US Pivotal Clinical Trial with RedHill's Crohn’s Drug – RHB-104

Apceth is Extending its Top Management: Prof. Ralf Huss Moves from Roche (RHHBY) to the Biotechnology Company apceth

BioIndustry Association Board Appointments

>> More in: Appointments

Recognitions

Journal names discovery that HIV treatment can prevent spread 'breakthrough of the year'

Abbott Laboratories's Absorb(TM) Bioresorbable Vascular Scaffold Honored with Wall Street Journal Technology Innovation Award

Chris Henney Receives 2011 Hall of Fame Award at Annual Biotech CEO Meeting at Laguna Beach

Scripps Florida Scientist Awarded $2.2 Million Grant To Study Hepatitis C

SAMHSA Awards Up To $25 Million To Expand Use Of Health Information Technology

Ablitech, Inc. Awarded $2 Million

The Michael J. Fox Foundation Awards AFFiRiS AG $1.5 Million for the Clinical Development of the First Parkinson's Disease Vaccine

SAMHSA Awards Grant To UCLA For Substance Abuse Prevention In Iraq

KGI Professor Awarded Patent For Stem-Cell Therapy Aiding Heart-attack Patients

Nobel Prize for chemistry 2011 goes to Israeli scientist Daniel Shechtman

>> More in: Recognitions